Nuzenio

Gej Cancer

Gej Cancer news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 9 publisher sources 100/100 entity strength

Latest news

EU Clears PD-L1 IHC 22C3 pharmDx as Companion Diagnostic for Pembrolizumab in Ovarian Cancer - OncLiveOncLive · Thu, 06 Aug 2026 13:13:30 GMT Shanghai SinoUnited Hospital Announced Availability of World's First CAR-T Therapy for Solid Tumors in Advanced Gastric Cancer - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 06:29:25 GMT Promising New Option for Claudin 18.2‑Positive Gastric and GEJ Cancer - news.cancerconnect.comnews.cancerconnect.com · Mon, 03 Aug 2026 17:25:49 GMT HER2-expressing metastatic G/GEJ cancer: Disitamab vedotin combinations extend 1L activity beyond HER2-high - Vera HealthVera Health · Sun, 02 Aug 2026 14:56:55 GMT MET-amplified G/GEJ cancer: Savolitinib shows later-line single-agent activity - Vera HealthVera Health · Fri, 31 Jul 2026 04:48:41 GMT Sonesitatug Vedotin Extends Survival in Advanced Gastric Cancer - Cure TodayCure Today · Wed, 29 Jul 2026 19:41:06 GMT KOL Views Preview: What to make of mixed survival data on AZ's Claudin18.2-targeting ADC in gastric cancer? - FirstWord PHARMAFirstWord PHARMA · Wed, 29 Jul 2026 03:15:19 GMT AstraZeneca's Claudin 18.2-targeting ADC passes pivotal gastric cancer test - FirstWord PHARMAFirstWord PHARMA · Mon, 27 Jul 2026 20:25:00 GMT

Timeline

Thu, 06 Aug 2026 13:13:30 GMTEU Clears PD-L1 IHC 22C3 pharmDx as Companion Diagnostic for Pembrolizumab in Ovarian Cancer - OncLive

Wed, 05 Aug 2026 06:29:25 GMTShanghai SinoUnited Hospital Announced Availability of World's First CAR-T Therapy for Solid Tumors in Advanced Gastric Cancer - The Manila Times

Mon, 03 Aug 2026 17:25:49 GMTPromising New Option for Claudin 18.2‑Positive Gastric and GEJ Cancer - news.cancerconnect.com

Sun, 02 Aug 2026 14:56:55 GMTHER2-expressing metastatic G/GEJ cancer: Disitamab vedotin combinations extend 1L activity beyond HER2-high - Vera Health

Fri, 31 Jul 2026 04:48:41 GMTMET-amplified G/GEJ cancer: Savolitinib shows later-line single-agent activity - Vera Health

Wed, 29 Jul 2026 19:41:06 GMTSonesitatug Vedotin Extends Survival in Advanced Gastric Cancer - Cure Today

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

GEJ6 live mentions Advanced Gastric Cancer4 live mentions Claudin4 live mentions Positive Gastric4 live mentions ADC4 live mentions The Manila Times3 live mentions Sonesitatug Vedotin Improves3 live mentions IHC2 live mentions Companion Diagnostic2 live mentions Pembrolizumab2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Gej Cancer.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.